Jim Cramer and Action Alerts PLUS Director of Research Jack Mohr discuss why they are buyers of Thermo Fisher (TMO) shares following their initiation on the name yesterday. Thermo Fisher is not only the standalone leader in life science tools but also the bastion of consistency. It has consistently delivered 17% annual earnings growth off mid-single digit organic revenue growth, which is representative of the company's ability to extract value, maximize efficiencies and drive productivity. Jim and Jack expect Thermo Fisher to drive sustainable growth through market leading brands and products, unmatched scale, and best-in-class distribution.